Association between Helicobacter pylori status and self-rated health : a population based cross sectional study. by Nilsson, Fanny
1 
 
  
Association between Helicobacter pylori 
status and self-rated health – a 
population based cross sectional study. 
 
Author: Fanny Nilsson 
 
Institutionen för mikrobiologi, tumör- och cellbiologi  
Fanny Nilsson 
Läkarprogrammet KI 
Examensarbete 30 p 
Vårterminen 2016 
 
Supervisor: Anna Andreasson 
 
2 
 
 
Association mellan Helicobacter pylori-status och självskattad hälsa – en populationsbaserad 
tvärsnittsstudie.  
 
Bakgrund: Halva jordens befolkning är beräknad att vara infekterad av Helicobacter pylori, men i 
80% av fallen är infektionen asymptomatisk. Det är inte känt huruvida infektionen med dess 
potentiellt kroniska låggradiga inflammation har en effekt på självskattad hälsa. Syfte: Att undersöka 
huruvida H. pylori -infektion är associerad med dåligt självskattad hälsa. Material och Metoder: 
Gastroskopi utfördes på 360 individer från Östhammars kommun, Uppland. Biopsier från magsäckens 
slemhinna togs för histologisk analys, samt blodprover för serologisk analys, för att upptäcka 
förekomst av H. pylori. Individerna skattade sin hälsa på en skala från 1-5. Resultat: Fjorton individer 
var positiva i serologi, medan 10 individer var positiva i histologi för H. pylori. Analys med logistisk 
regressionsmodell visade ingen significant statistisk association mellan H. pylori och självskattad 
hälsa. Slutsats: Vi fann inte  någon korrelation mellan  förekomst av H. pylori-infektion och lägre eller 
högre självskattad hälsa. 
 
 
 
Association with Helicobacter pylori status and self-rated health – a population based cross 
sectional study. 
 
Introduction: Half of the world’s population is estimated to be infected with Helicobacter pylori, 
although in 80% of the cases the infection is asymptomatic. It is not known whether the infection with 
its potential chronic low-grade inflammation has an effect on self-rated health. Aims: To investigate if 
H. pylori infection is associated with poor self-rated health. Materials and Methods: 
Esophagogastroduodenoscopy was conducted at 360 individuals from Östhammar municipality, 
Uppland, Sweden. Biopsies for histology from the ventricular mucosa as well as serology from blood 
samples were taken in order to detect H. pylori. The individuals rated their health on a scale of 1-5. 
Results: Fourteen individuals were positive on serology, while 10 individuals were positive on 
histology for H. pylori. Analyzing with logistic regression model, we did not find a significant 
statistical association between H. pylori and self-rated health. Conclusions: We have not found any 
correlation between H. pylori infection and lower or higher self-rated health. 
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Introduction 
 
Helicobacter pylori 
It happens rarely in modern medicine that a completely new etiology for a disease is found – 
especially a microbial one. Ever since the revolutionizing discovery of Helicobacter pylori 
(H. pylori) and its correlation to gastritis and peptic ulcers in 1982 by Barry Marshall and 
Robin Warren (1), H. pylori has also been shown to be a major cause of duodenal and gastric 
ulcer disease, and to be associated with gastric lymphoma and gastric cancer in humans (2). 
The infection most commonly occurs during the first years of life and persists lifelong, if 
untreated. The prevalence varies with socioeconomic status during childhood, and thus also 
varies between countries and generations. Around half of the total population in the world is 
estimated to be infected by H. pylori, making it one of the most common human infections in 
the world (3). The prevalence in Sweden is estimated to be around 30%, ranging from 15% 
among the youngest and >50% among the elderly – a difference that is thought to depend on 
living standards during childhood. In lower income countries, around >90% can be infected 
(4). Since its discovery, over 50 extra-gastric manifestations have also been reported and 
discussed in relation to H. pylori in medical literature in a wide range of different medical 
areas, with more or less compelling evidence (3). 
Symptoms in the epigastrium that are supposed to originate from the upper gastrointestinal 
tract are called dyspepsia. Dyspepsia can be either idiopathic, which is most common, or be 
caused by an organic disease, where symptomatic H. pylori infection is one potential 
etiological agent. When no cause is found, the term functional dyspepsia or non-ulcer 
dyspepsia is used, according to the internationally used Rome criteria (5). Functional 
dyspepsia is defined as having one or more of the symptoms bothersome postprandial 
fullness, early satiation, epigastric pain and epigastric burning. For a more severe H. pylori 
infection, causing ulcers or even cancer, other symptoms or signs such as anemia, dysphagia 
and bloody stool can occur (4).  
The aim in international clinical practice has consequently been to eradicate H. pylori when 
found in dyspeptic patients, after an upper GI endoscopy or EGD 
(esophagogastroduodenoscopy) has shown an ulcer. Eradication therapy (antibiotics and 
proton pump inhibitors) is sometimes given even without testing for H. pylori when duodenal 
ulcers are found. The reverse method is also accepted for practice, with the newer “test and 
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treat” strategy patients with dyspeptic symptoms showing positive for H. pylori using urea 
breath test (UBT) or Fecal Helicobacter pylori-Antigen ELISA (F-Hp) are given eradication 
therapy without a preceding EGD (4). 
However, with around half of the global population infected with H. pylori, the bacterium 
leaves its host asymptomatic in around 80% of all cases. It is thus one of few infections that 
cause a chronic inflammatory response without giving disease or symptoms in the majority of 
the infected patients (4).  
Ecosystem hypothesis 
In recent years, new hypotheses concerning a potential protective role of H. pylori infections 
have been explored. The theory of evolution claims that if there is a survival benefit for the 
host, the organisms within its body will continue to thrive. Maixner et al have demonstrated 
H. pylori genome findings from the glacier mummy “Ötzi”, estimated to have lived 5300 
years ago (6), while  Linz et al suggested a human-bacterial coexistence as far as 58 000 years 
back, based on their findings that H. pylori genetic diversity follow similar patterns as human 
migration from east Africa (7). It is thus rather clear that humans have been infected for a 
long period of time. Furthermore, H. pylori only has one niche for living: the human stomach 
(1). The question is hence posed: is this relationship mutualistic, commensal or parasitic? The 
explanatory model for the human body as an ecosystem has gained a lot of interest, especially 
in research of autoimmune diseases, where the immune system is proposed to be so 
“unstimulated” that it instead attacks the own tissues (8). Popularly, this has been called the 
hygiene hypothesis (9). 
In an article, Smyk et al, presented that over one hundred autoimmune diseases have been 
studied concerning their correlation to H. pylori, with very mixed results (10). In a review on 
the controversial topic, Daugule et al show that could be some evidence from observational 
studies supporting a weak inverse relation with H. pylori and allergy, but on the other hand 
points out that this is difficult to adjust for confounders such as geography and socioeconomic 
factors, known to influence H. pylori prevalence. Furthermore, the authors proposed that H. 
pylori is a major stimulus for the generation of T-regulatory immune cells, that is important in 
the development of a healthy immune system (11). The possible correlation between 
autoimmunity and H. pylori is however debatable, and was recently dismissed by well-
respected H. pylori researcher David Graham, who claimed that the evidence was weak and 
that H. pylori could merely be a marker for poor hygiene. An environment generally richer of 
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different organisms is what the hygiene hypothesis really comprises, he argues – not one 
single bacterium (12). 
H. pylori and the stomach 
The main pathology associated with H. pylori is gastritis and consequently peptic ulcer 
disease (PUD) (1). The correlation between the bacteria and mucosal inflammation was also 
the findings Robin and Marshall made in their first article about the “unidentified curved 
bacilli” (13). 
Since the discovery of H. pylori, the prevalence has decreased steadily in more developed 
countries, most often explained by increased living standards and improved sanitation (14). 
Oral-to-oral and fecal-to-oral is believed to account for most transmission of the infection, 
although there is not yet complete understanding in the medical society of the transmission 
routes (1). During the same time period, effective medical treatment for PUD has dramatically 
improved, with proton pump inhibitors (PPI:s) and antibiotic treatment for ulcers in clinical 
practice (15). As a consequence, elective surgery for ulcers has virtually disappeared, which 
Paimela et al concluded in a Finnish nationwide database study (15). Between the years 1987 
and 1999 elective PUD surgery decreased from 15,7 to 1,7 operations per 100 000 inhabitants 
(p < 0,05) in Finland. On the contrary, in the same study emergency surgery increased from 
5,2 to 7 operations per 100 000 inhabitants (p < 0,05). Manuel et al demonstrates a similar 
paradoxical trend: in their study including five large US teaching hospitals from 1996 to 2005, 
PUD as a primary or secondary discharge diagnosis did not significantly decrease, although 
H. pylori prevalence had steadily decreased in the country (16). The authors discussed 
whether their study might combine two opposing trends, as use of non-steroid anti-
inflammatory drugs (NSAIDs), the second most common etiology for PUD, had increased 
during the same time period. A systematic review conducted by Sung et al including 18 
studies with at least 1000 subjects in sample size, demonstrated that both incidence and 
prevalence of PUD have decreased over the last decades (17). However, the authors also 
recognize that hospitalizations and complications of PUD were not decreasing in some of 
these studies, and also attributed this to use of low-dose ASA, NSAIDs and incomplete 
application of gastroprotective medication. 
While ulcers are the clear main pathology associated with H. pylori, in some of the infected 
individuals the inflammation could lead to atrophy and intestinal metaplasia of the ventricular 
mucosa – and eventually develop into gastric cancer. If these cell changes already have 
6 
 
occurred, the increased risk of gastric cancer persists even though H. pylori is successfully 
eradicated – “the point of no return” (4). But how important is the carcinogenic potential of 
the bacteria? In a systematic review by Cochrane from 2015, the researchers investigated 
whether treating those infected with H. pylori, using antibiotics, could decrease the number of 
new cases of gastric cancer. Six randomly controlled trials were included, where patients were 
given either antibiotics or placebo to H. pylori positive asymptomatic adults. Fifty-one (1.6%) 
of 3294 participants given treatment developed gastric cancer, compared with 76 (2.4%) of 3203 
given placebo (RR: 0.66, 95% CI 0.46 to 0.95). The subjects were followed during at least two 
years. The authors concluded that the evidence for that a search and eradicate strategy in 
preventing gastric cancer was limited, although this evidence was of moderate-quality (18). 
However, the Japanese health insurance system started in 2013 to cover eradication for all 
patients infected with H. pylori in order to prevent gastric cancer, which might entirely 
eradicate the infection in the country (19). 
H. pylori and the esophagus 
Epidemiological studies have repeatedly demonstrated a negative correlation between H. 
pylori infection and erosive esophagitis, Barrett’s esophagus and esophageal adenocarcinoma 
(20). The strategy of the bacteria to survive the acidic conditions in the stomach is to have a 
large enzyme that produces urease, creating an alkaline environment around it (2). Moreover, 
the immune response to the infection involves several cytokines, such as IL-1β, which exerts 
a 100-fold and 6000-fold more potent inhibition of acid secretion than the common drugs for 
decreasing symptomatic stomach acidity (PPIs and histamine-2 receptor antagonists 
respectively) (19). In addition, the mucosal atrophy that the chronic inflammation leads to 
decreases the acid secretion even more. In total, the reduced acidity in the stomach is thought 
to lead to decreased reflux damage on the esophagus, and hence explain the negative 
correlation between H. pylori and esophageal conditions (20). 
On the other hand, whether eradication therapy really does induce gastroesophageal reflux 
disease (GERD), which is considered to be a pre-state to the other esophageal diseases 
mentioned, is debatable. Large review studies have come to discordant conclusions: Tan et al 
examined 16 cohort studies and found that H. pylori eradication therapy had no significant 
effect on the occurrence at GERD (OR: 0,87, CI: 95%), (21) while Xie et al examined 43 
case-control, cohort and randomized-controlled studies and found an increased risk for GERD 
after H. pylori eradication (RR from 1,70 to 2,50, CI: 95%) (22). However, considering the 
epidemiologically shown negative association with the other diseases in the esophagus 
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discussed previously, it would seem like H. pylori infection might be protective for the 
esophagus (20).  
H. pylori and anemia 
Persisting inflammation in the gastric mucosa could not only induce metaplasia and/or gastric 
cancer, it could also result in atrophic gastritis, leading to a significant reduction in the 
production of the important intrinsic factor (IF). Vitamin B12, essential for DNA synthesis, is 
dependent on IF for its uptake more distally in the gastrointestinal tract, and the first 
manifestation of vitamin B12 deficiency is a reduced production of blood cells. Pernicious 
anemia, caused by vitamin B12 deficiency, was the first extragastric manifestation of H. 
pylori recognized, and eradication of the bacteria has been included in international 
management guidelines when this deficiency is found (3). 
Iron, the other big part in deficient anemia has also been connected to H. pylori infection (2). 
Here, the pathophysiology is not yet fully understood, apart from the evident bleeding from H. 
pylori ulcers. The recently discovered hormone hepcidin has been proposed to be of 
importance in anemia without a known cause. It is released by the liver and regulates iron 
metabolism in erythrocytes, and rises as an acute phase reactant in response to the mucosal 
inflammation following H. pylori infection. Studies have shown that serum hepcidin is 
increased in H. pylori infected individuals, and decreases after eradication. Anemia of 
inflammation or chronic disease is seen in many other conditions – H. pylori infection is both 
inflammatory and chronic (3). The Maastricht guidelines include unexplained iron deficiency 
anemia in the cases where H. pylori should be sought and eradicated (2).  
H. pylori and coronary heart disease 
Cardiologists have also turned their attention to H. pylori infection. The theory of systemic 
low grade inflammation being a trigger for atherosclerosis has been a research field of 
interest, with correlation between IL-6, C-reactive protein and coronary heart disease (CHD) 
in particular (24, 25). Different microbial associations to CHD such as Chlamydia pneumonia, 
Hepatitis C virus, cytomegalovirus and H. pylori have all been proposed and to different 
extent significantly supported (26-28). H. pylori has been found in the coronary arterial wall 
in patients undergoing coronary bypass grafting (29), but the importance of the bacteria’s 
general risk increase for CHD seemed in that study to be of less importance compared to other 
risk factors for CHD (30, 31).  
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Self-rated health 
The question is therefore raised: is H. pylori a friend or a foe? Giving the well-known direct 
causal relation to PUD and gastric cancer, the answer should be that the bacteria is a mere 
parasite, but the reality might be more complex. Today there is no consensus concerning the 
coexistence between humans and the bacteria: who benefits and who becomes ill – and if 
there is a price to extinguishing H. pylori from the human flora. Risks and comorbidity aside, 
for this study we have chosen to look at how carriers of H. pylori rated their health. Given that 
the infection is asymptomatic in 80%, the question arises whether the potentially low grade 
inflammation could impact the perceived general health status.  
Poor self-rated health has been proven an independent predictor of both mortality and 
morbidity, including diseases such as diabetes, cancer and cardiovascular disease (32). A 
single general question of the type “How would you rate your general health status?” 
(different wordings used), with a 5-point response scale, from “very good” to “very poor” has 
a predictive capacity of objective health status independent of age, gender, socioeconomic 
status, country of origin and cognitive function (33).  
There have been many theories regarding the mechanisms of this correlation (33), where the 
most interesting for our study concerns inflammation and cytokines. Many studies have 
previously shown independent correlations between inflammatory factors and self-rated 
health (33). In one study, published by Lekander et al (34), the correlation between self-rated 
health, cytokine levels and physician rated health was examined. The physicians rated the 
subjects’ health using a scale of 1-5 (Healthy/1, Healthy with slight problems/2, Fair/3, Rather 
poor/4, Poor/5) strictly based on medical criteria in a questionnaire filled out by the doctor 
after consultation – a method that has proven good interrater reliability (35). The authors 
found that poor self-rated health was correlated to high cytokine levels independently of 
physicians’ rating (34). It is plausible that asymptomatic H. pylori infection could elicit a low-
grade inflammatory response, detectable in the measure of self-rated health. 
Modern medicine is a discipline focused on objective findings; laboratory results, radiological 
findings, histological diagnostics and visual, hearable and palpable abnormalities. Although 
very well validated, self-rated health is currently not used in clinical practice, even though 
there often is a large discrepancy between patient-rated and physician-rated symptom burden 
and functional limitations (36). This study will not answer the underlying question whether H. 
pylori is on average beneficial or harmful to humans concerning mortality or morbidity. 
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However, it will examine whether people infected with H. pylori might have a worse self-
rated health than those non-infected, which to our knowledge has not been studied before. 
 
Aims 
To investigate if H.pylori infection is associated with poor self-rated health.  
Our hypothesis is that that individuals positive to H. pylori biopsy (i.e. ongoing infection) 
have a lower self-rated health, due to an increased risk of dyspepsia, but also the potential 
negative impact of low-grade chronic inflammation on self-rated health. 
Do individuals with H. pylori positivity on histology and/or serology rate their health as 
worse compared to individuals without H. pylori positivity, independent of age, gender and 
education? 
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Materials and methods 
The study has used a cross-sectional design within a longitudinal population based study 
(LongGERD) (37), as we were interested in the general health experience of being a H. pylori 
carrier, not the risk of future complications. 
Population 
In December 2010, the municipality of Östhammar, Uppsala county, had 21 373 inhabitants. 
It is partly a coastal region with its shore on the Baltic Sea, situated approximately 100 km 
north of Stockholm. Historically, the municipality was chosen for the study partly due to that 
the distribution by age, gender, family size, income, occupation, and other socioeconomic 
variables is largely similar to the national average. Ninety-two percent of the residents were 
Swedish citizens (37).  
The study participants were found through mailing of a symptom questionnaire (The 
Abdominal Symptom Questionnaire, ASQ) to all adults above 20 years old in Östhammar 
municipality born on day 3, 12 or 24 in each month. The invitation procedure was equivalent 
to random sampling, as well as it allowed for follow up studies. Two individuals had 
protected identity, nine individuals had moved out of the country and four individuals had 
denied participation in the prior studies in LongGERD, and these were all excluded. The 
research team chose to include all participants from the three prior studies who had moved out 
of the municipality. These participants had been included in the prior studies using the same 
methodology. This resulted in a final study population of 1924 individuals. Sixty-one 
individuals of these were unavailable, so 1863 individuals were mailed the questionnaire in 
late 2011. A total of 1175 (63,1%) responded. See fig. 1.  
Serology and biopsies 
In the group of the 1175 responders, 1034 were under the age of 80 years and lived within 200 
km from the study center, and were eligible for esophagogastroduodenoscopy (EGD). 
Participants >80 years old were excluded due to it not being considering ethical given their 
age to conduct such an invasive examination as EGD. Forty-five individuals were excluded 
due to the preset contraindications for EGD, see fig 2. The remaining individuals were invited 
by telephone by research assistants, who gave verbal information on informed consent. A total 
of 402 (42,5%) accepted to participate and signed a written consent form. Out of these, 14 
individuals discontinued the process, leaving 388 (40,8%) completing the EGD. See fig. 1. 
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- unstable angina or myocardial 
infarction 
- heart disease or failure 
- recent cerebral infarct or bleeding 
- mental retardation or dementia, 
- psychosis and other severe 
mental disorders 
- anticoagulation therapy or known 
bleeding tendency 
- known esophageal varicose veins 
alcoholism 
- previous upper gastrointestinal 
surgery (excluding 
cholecystectomy) 
- lung disease with low respiratory 
capacity 
- current malignant disease 
- pregnancy 
Fig. 1. Inclusion of subjects in the Helicobacter 
pylori Östhammar study. Flow chart of inclusion 
of study subjects for endoscopy (EGD) comprising 
drop-out and reasons for drop-out. The subjects 
were identified based on day of birth in every month 
(3
rd
, 12
th
, 24
th
), which gives a random selection. 
Abbreviations: ASQ = Abdominal Symptom 
Questionnaire, EGD = esophagogastro-
duodenoscopy. 
Fig. 2. Exclusion criteria in the 
Helicobacter pylori Östhammar 
study - contraindications for 
endoscopy. List of previously 
defined contraindications that 
excluded potential participants 
from undergoing endoscopy. 
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At the day EGD was performed, blood samples for standard blood tests and serology were 
drawn. Biopsies for histology were taken from multiple sites by five experienced 
endoscopists, who were unaware of the patient’s medical history and H. pylori status of the 
participants. A positive result of H. pylori serology reflected whether an individual had 
encountered the bacteria and had a competent immune response, while biopsies detected an 
ongoing infection. One of the patients in the study reported having gone through eradication 
treatment. 
Serum stored in -70 degrees C was used for a test panel on levels of IgG class antibodies to H. 
pylori (GastroPanel, Biohit Plc., Helsinki, Finland). Five blood tubes were drawn, and CRP, 
Hb, cholesterol, creatinine and ALAT was also analyzed for future studies. Two biopsies were 
taken from both the antrum and the corpus for H&E staining and W.S. staining, and assessed 
by the Sydney System by two experiences pathologists. The pathologists were blinded, but 
afterwards the histology for the participants that were H. pylori positive on serology and 
negative on W.S. staining on histology was reviewed.  
Self-rated health 
Self-rated health was included in the mailed questionnaire. The question was formulated 
“How would you rate your general health status?” rated on a five point scale. The response 
alternatives were very good, rather good, neither good nor poor, quite poor or very poor 
(coded 1-5). The first round of questionnaires was sent out in October 2011. The first 
endoscopies started in beginning January 2012. The individuals did thus respond to their 
health status some weeks or months earlier than they were examined with EGD and blood 
samples, depending on how fast they answered and when they were scheduled for EGD. 
Hypothetical maximum time between questionnaire and EGD were six months. If considering 
that H. pylori could be a chronic infection, this time gap was not considered to be of any 
significant importance for the analysis. The possibility of new infections occurring during the 
time gap was very low, since infection most often occurs the first years of life (38). As the 
self-rated health variable was available from all individuals that responded to the 
questionnaire (63,1%) it was used to investigate any bias in self-rated health between those 
who had the EGD and those who did not. 
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Statistical method 
Logistic regression was used when analyzing whether subjects with a lower self-rated health 
were more prone to go through the EGD investigation, using self-rated health as the 
independent variable and EGD participation as the dependent variable. Logistic regression 
analysis was used to test if persons with H. pylori positivity reported worse self-rated health 
by using H. pylori status as the dependent variable and self-rated health as the independent 
variable. This was done for histology and serology positivity respectively. Logistic regression 
was used as H. pylori status and EGD participation respectively were dichotomous variables 
while self-rated health was an ordinal variable. In these analyses, self-rated health was 
analyzed as a categorical variable using the response alternative “very good” as reference. All 
analyses were adjusted for age, gender and educational level. Self-rated health was also tested 
as a continuous variable in a logistic regression to investigate whether self-rated health, age or 
education affected the likelihood to go through the EGD.  
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Ethical considerations 
All participants have given oral and written consent. Five blood tubes were drawn and 2 
serum and 2 plasma tubes were stored in Uppsala Biobank for future studies. Conventional 
blood status analysis was made (CRP, hemoglobin, cholesterol, creatinine and ALAT), as 
well as serology analysis of H. pylori. Furthermore was brush test of the esophagus, stomach 
and duodenum performed at the same sites as the biopsies, for future studies. 
Participants were given information on the risks of EGD. The patients underwent a very 
unpleasant examination, associated with some risks. Sedatives (sublingual diazepam) were 
offered if patients requested in order to reduce suffering. However, they were treated if 
pathologies were found, which could be seen as a benefit outweighing the risks for the 
participants. It could also be an incentive for the subjects to choose to participate which could 
lead to a selection bias of the population. This possibility was taken into consideration in the 
data analysis. Approval for the study was obtained from the Ethics Committee of Uppsala 
University on January 26th, 2011 (Dnr. 2010/443). 
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Results 
Data for self-rated health was missing for 30 out of the 947 who responded to the 
questionnaire and were eligible for EGD. Educational level data was missing for 16 of these 
participants, leaving 901 available for analysis. See fig. 3. Similarly self-rated health data, 
correct biopsy and educational data were  missing for 28 of the EGD examined individuals, 
leaving 360 out of the original 388 available for analysis. See fig. 4. For all of these 360 
individuals serology data was available.  
 
 
 
 
 
 
 
 
The population characteristics are presented in table 1. Higher education was defined as 
completed college or university studies. The population who conducted EGD was very similar 
to the population who declined. The average age for those who are positive for H. pylori is 
slightly higher than in the other groups, which is expected, since infection often occurs in 
childhood and is correlated to living standards (4). 
  
Figure 3. Data fall-out of the total subject 
group in the Helicobacter pylori 
Östhammar study. Flow chart depicting how 
many subjects dropped out from statistical 
analyses due to incomplete responses. 
Abbreviations: ASQ = Abdominal Symptom 
Questionnaire, EGD = esophagogastro-
duodenoscopy. 
Figure 4. Data fall-out of the group 
that underwent endoscopy in the 
Helicobacter pylori Östhammar 
study. Flow chart depicting how many 
subjects dropped out from statistical 
analyses due to incomplete responses 
or missing biopsy data. Abbreviations: 
EGD = esophagogastroduodenoscopy. 
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Potential selection bias 
EGD is an uncomfortable examination to undergo and there is a risk for selection bias: The 
individuals choosing to participate could have more gastric symptoms and lower self-rated 
health which might make them more prone to undergo 
invasive investigations. In the present study self-rated 
health did not influence participation rate. The data for 
self-rated health the two different groups is presented 
in table 2. There is no compelling difference in the 
population that answered the questionnaire (n=901) 
and the EGD population (n=360) considering self-
rated health when analyzing with logistic regression.  
Individuals rating their self-rated health as level 2 and 
4 were more prone to agree to EGD than individuals 
with very good health (self-rated health 2/rather good 
odds ratio (OR)=1.77, p=0.00; self-rated health 4/quite 
Population information All 
eligible 
Done 
EGD 
Positive 
Histology 
Negative 
Histology 
Positive 
Serology 
Negative 
Serology 
Higher education (%) 62,15 62,50 42,86 65,09 48,21 65,13 
Women (%) 52,16 51,11 38,09 52,83 48,21 51,64 
Mean age (years) and 
SD (years) 
53,42 
(SD 
14,42) 
54,10 
(SD 
13,21) 
59,30 (SD 
12,68) 
53,41 (SD 
13,14) 
60,71 (SD 
12,34) 
52,88 (SD 
13,02) 
Minimum age (years) 20 20 28 20 28 20 
Maximum age (years) 79 79 78 79 78 79 
Mean and SD of SRH 
(1-5) 
1,93 (SD 
0,79) 
1,98 (SD 
0,74) 
1,83 (SD 
0,54) 
2,00 (SD 
0,76) 
1,96 (SD 
0,85) 
1,98 (SD 
0,72) 
Total number (n) 901 360 42 318 56 304 
SRH No  
EGD 
Did 
EGD 
Total 
1 175 86 261 
2 260 224 484 
3 77 45 122 
4 11 14 25 
5 7 2 9 
Total 530 371 901 
Table 1. Subject population demographics in the Helicobacter pylori Östhammar study. 
Population characteristics for all of the endoscopy eligible participants, the population who conducted 
the endoscopy and the populations who were positive and negative for H. pylori on histology and 
serology. 
Table 2. Self-rated health of 
endoscopy willing and non-willing 
subjects in the Helicobacter pylori 
Östhammar study. Self-rated health 
status (1-5) for those who conducted 
the esophagogastroduodenoscopy 
(EGD) and those who did not. 
Abbreviations: SRH = self-rated health, EGD = esophagogastroduodenoscopy. SD = standard 
deviation. 
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poor OR=2.69, p=0.02, adjusted for age, gender and educational level). On the other hand, 
there was no significant difference for those who rated their health as level 3/neither good nor 
poor or 5/very poor. There is thus a slight tendency that those who went through EGD had a 
worse self-rated health, but it is not convincing. Furthermore, when analyzing self-rated 
health as a continuous variable there were no increased tendency to go through EGD 
concerning SHR, age or educational level (data not shown). 
Helicobacter pylori and self-rated health 
For the analysis of H. pylori status and its association to self-rated health logistic regression 
was used. The binary dependent variable was H. pylori positivity and self-rated health was the 
independent variable. Gender, age and educational level were included as covariates. Data for 
self-rated health, serology and histology status are presented in table 3 and 4, and fig. 5 and 6. 
The group of previously but not currently infected (serology: n=56 minus histology: n=42 
gives n=14) was too small to be analyzed. The analysis showed that there was no significant 
difference in self-rated health between participants that were H. pylori positive and 
participants that were negative, neither for histology nor serology. The odd’s ratio, p-value 
and confidence interval for the different self-rated health levels are shown in table 5. For the 
analysis of histology, self-rated health 3-5 (neither good nor poor, rather poor and very poor) 
has been summarized due to too few positive subjects. 
 
 
 
  
SRH Negative 
Serology 
Positive 
Serology 
Total 
1 69 14 83 
2 184 35 219 
3 39 4 43 
4 12 1 13 
5 0 2 2 
Total 
(n) 
304 56 360 
Table 3. Helicobacter pylori 
serology status of partipants in the 
Östhammar study. Number of 
individuals positive and negative on 
H. pylori serology test, presented in 
relation to their answer of self-rated 
health (1-5). 
Figure 5. Helicobacter pylori serology status 
of partipants in the Östhammar study. 
Percentage of total group positive and total 
group negative on H. pylori serology test, 
presented in each self-rated health (SRH) level. 
The data is presented in percentage due to the 
large variation in number size of the group of 
positive and negative individuals. 
Abbreviation: SRH = self-rated health. 
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SRH 
Negative 
Histology 
Positive 
Histology 
Total 
1 73 10 83 
2 190 29 219 
3 40 3 43 
4 13 0 13 
5 2 0 2 
Total 
(n) 
318 42 360 
SRH Odd’s ratio P-value Confidence 
interval 95% 
 Serology   
2 1,05 0,89 0,52-2,11 
3 0,52 0,28 0,155-1,73 
4 1,68 0,48 0,39-7,20 
 Histology   
2 1,17 0,7 0,53-2,57 
3 0,42 0,21 0,11-1,63 
Table 5. Logistic regression analyses of individuals positive for Helicobacter pylori on 
histology and serology in the Östhammar study. Logistic regression analysis was used to test if 
persons with H. pylori positivity reported worse self-rated health by using H. pylori status as the 
dependent variable and self-rated health as the independent variable. Self-rated health was 
analyzed as a categorical variable using the response alternative “very good” as reference. 
All analyses were adjusted for age, gender and educational level. 
Abbreviation: SRH = self-rated health. 
Figure 6. Helicobacter pylori histology status 
of partipants in the Östhammar study. 
Percentage of total group positive and total 
group negative on H. pylori histology, 
presented in each self-rated health (SRH) level. 
The data is presented in percentage due to the 
large variation in number size of the group of 
positive and negative individuals. 
Table 4. Helicobacter pylori 
histology status of partipants in the 
Östhammar study. Number of 
individuals positive and negative on 
H. pylori histology, presented in 
relation to their answer of self-rated 
health (1-5). 
19 
 
Discussion 
It is not known how and if asymptomatic H. pylori infection affects the subjective health, as 
well as to which extent it is a protective or a risk factor for other diseases. This study was 
aimed at investigating the subjective health of people infected with H. pylori compared to 
those not. The prevalence of H. pylori was tested using blood serology and biopsies from the 
ventricular mucosa, while self-rated health was measured using a questionnaire. The 
hypothesis was postulated that individuals positive to H. pylori  biopsy (i.e. ongoing 
infection),  have a lower self-rated health, due to increased risk of mainly dyspepsia and 
anemia, but also the potential negative impact of low-grade chronic inflammation on self-
rated health. In the study, we could however not find any such association that was 
statistically significant. 
The lack of association between self-rated health and H. pylori infection in the present study 
is in line with previous research on the relationship between self-rated health and other 
”silent” pathogens. In a study from 2009, Steptoe et al did not find a correlation between self-
rated health and Chlamydia pneumonia, cytomegalovirus, HSV-1, and seropositivity for 
Borrelia Ig (39). To the best of our knowledge, this is the first study on self-rated health and 
H. pylori.  
Furthermore, asymptomatic pathogens such as H. pylori have been investigated concerning 
mortality. In a previous epidemiological study, Simanek et al investigated whether total 
pathogen burden as well as single and combined burden of CMV, HSV-1, HSV-2 and H. pylori 
were associated with all-cause mortality. The study included 6522 individuals and no 
statistically significant relationship between infectious burden and all-cause mortality was 
found (40). Even though our study has not investigated the mortality, H. pylori infection as a 
risk factor for gastric cancer and maybe a potentially protective factor for esophageal cancer, 
and hence mortality, is at the center of clinical decision-making on eradication. Our findings 
may add to this decision-making, as we cannot find an indication for eradication therapy 
based on self-rated health. Low ratings of self-rated health are in itself an independent 
predictor of mortality (33), something that H. pylori positive subjects in this study did not 
show. 
On the other hand, our results may seem to be in contrast with previous findings that H. pylori 
was associated with higher Interlekukin-6 (IL-6) (41) – the most widely studied cytokine that 
has in its turn been associated with worse self -rated health independently of background 
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factors (33). In the specific study, Nakagawa et al found that H. pylori-positive individuals 
with a higher anti-H. pylori IgG titer had a higher concentration of IL-6, adjusted for age, sex 
and atrophic gastritis (β=0,18, p=0,012). According to the authors of the specific study, this 
suggests that H. pylori infection could cause a systemic inflammation, which in its turn could 
be associated with a worse self-rated health (33). However, the subjects included in the study 
had come to a clinic because they were worried about H. pylori, and could therefore 
potentially be more symptomatic than the average asymptomatic carrier which we have been 
investigated in the present study. 
We did not have the opportunity to investigate inflammatory factors in our study, but 
Nakagawa and colleagues’ findings are interesting when considering research on cytokines 
and self-rated health. Undén et al have examined the correlation between self-rated health, 
symptoms (defined as “disease behavior”) and cytokines in 174 female consecutive primary 
health care patients (42). As thought, women with more disease behavior (based on ratings of 
energy, sleep, appetite, fitness, memory and pain), showed lower self-rated health and higher 
cytokine levels. Importantly, self-rated health and cytokine levels were associated even in the 
asymptomatic women, mainly for TNF-α (18-64 years, β=0,29 p<0,001, >65 years β=0,34 
p<0,001). Although the cross sectional design of the study precludes any conclusions about 
causality, it may be plausible that low-grade inflammation without symptoms still can affect 
the perceived health, which would contrast to our findings. 
Strengths and limitations 
In the present study we did not find a significant association between H. pylori status and self-
rated health. The included population was generally very healthy and few individuals were 
positive for H. pylori serology and histology which reduced the power of the statistical 
analyses. Since EGD is an invasive investigation, 45 subjects were excluded due to 
contraindications, e.g. for recent myocardial infarction and no serology for H. pylori was 
taken. If these subjects were too sick to be included, their self-rated health would potentially 
be lower, and this combined with their H. pylori status could have been a way to increase the 
variance in health status among the participants. Furthermore, H. pylori and low-grade 
inflammation as a risk factor for cardiovascular disease is much debated in medical literature 
as previously discussed in this paper, why individuals suffering from more severe heart 
disease would have been interesting to include in the study. 
21 
 
Self-rated health is a very well validated measurement, although broad. The different diseases 
associated with H. pylori in both negative and positive manner come with a range of 
symptoms, which would be interesting to investigate in a more extensive study. Possibly, the 
H. pylori positive subjects are generally more tired, or have more problems concerning their 
stomach, without it affecting the rough measurement of self-rated health. In the questionnaire 
used in the inclusion, symptoms like this were asked for using a widely utilized questionnaire 
called Short form health survey (SF-36). Analysis of these answers might have made this 
study more nuanced in the understanding of the eventual impact of H. pylori on the 
individuals’ health. SF-36 is a measure of health related life quality, and not a measure of 
self-rated health – although the two measurements combined could create a fuller 
understanding of seemingly asymptomatic H. pylori infection. 
Furthermore, due to technical problems with the self-rated health questionnaire collection on 
the day of EGD, self-rated health data from the inclusion questionnaire was used for the 
analysis instead. This means that the subjects responded to their health status some weeks or 
months before the EGD and blood samples, with the hypothetical maximum time between the 
questionnaire and EGD of six months. H. pylori is a chronic infection, and it occurs mostly 
during the first years of life (38), thus this flaw is not thought to influence the results 
significantly. However, it is methodically not intended and not correct in a cross-sectional 
study to have such a large time gap between two variables that are hypothesized to be 
associated. 
Another limitation in the study is that we did not measure the subjects’ cytokine levels. Since 
these could be important in the discussion of self-rated health and potential low-grade 
inflammation, it would have made this study more robust and relevant in its conclusions. 
The strength of this study is that the cohort is large. We have used two of the most reliable 
measuring methods available for detecting H. pylori, serology and histology. The specificity 
and sensitivity of the serology test for discovering H. pylori antibodies were 97% and 96% 
respectively (38), and the pathologists that studied the biopsies were blinded. Another 
strength of our study is that the population that was investigated with EGD was a 
generalizable sample compared to the Swedish population. 
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Clinical significance 
The newest Maastricht Guidelines from 2012 state that “H. pylori-positive patients with fear 
of gastric cancer should receive eradication treatment.” (2). By stating this, the authors make a 
strong case for global eradication, i.e. antibiotic treatment of half of the world population – 
since no one wishes to have cancer. The effect of this is not known. Klebsiella, Candida and 
Streptococcus viridans are organisms viewed as part of the normal human microbial flora, 
with the potential of becoming opportunistic pathogens, especially in the elderly or 
immunocompromised population (43), but there is no attempt to eradicate these from the 
bodies of worried patients. The comparison is however haltering since these potential 
pathogens do not cause cancer, but only infections. Nevertheless, the effect on the fecal 
microbiota of widespread eradication antibiotic use is not known, nor is the risk of 
Clostridium difficile associated diarrhea or subsequent antibiotic resistance. The Maastricht 
approach or the “test and treat” strategy (4) does not take this into account. The complex 
biological interplay between humans and the commensal organisms harboring in our bodies is 
only in the beginning of being understood. Pflughoeft et al states: “Human biology can no 
longer concern itself only with human cells: Microbiomes at different body sites and 
functional metagenomics must be considered part of systems biology.” (44) 
Our study has not found any significant association between H. pylori positivity and self-rated 
health. If these patients should be treated with eradication therapy, it would be in order to 
calm their worries, or to reduce risks of future diseases – not to increase their general health 
status. However, the potential reduction in risk for esophageal cancer with H. pylori infection 
has to be evaluated compared to the increased risk for gastric cancer. Likewise, although more 
speculative and with less compelling evidence, should the potentially increased risk for 
coronary heart disease with H. pylori infection be evaluated compared to a potentially 
protective effect on allergy. Lastly, of course, the risk for peptic ulcer disease with following 
complications needs to be added into this cost-benefit equation. Which disease of these is 
affects the most and is the most harmful? A thorough evaluation of these questions is needed. 
Future studies 
It was originally our intention to compare those individuals positive on serology and not 
histology, i.e. seroconverted, with those positive on histology, i.e. currently infected. H. pylori 
is generally a life-long infection, (38) but the vast use of antibiotics in modern health care is 
thought to contribute to “accidental” eradication (37). Unfortunately, the seroconverted group 
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was too small (n=14) for analysis. The two groups are interesting from different hypotheses. 
If the hygiene hypothesis for H. pylori is true and significant (i.e. H. pylori infection in early 
age helps to educate and train the immune system and prevents autoimmune diseases, see the 
earlier discussion in this paper) the previously infected individuals could reap the benefits of 
the infection but after that be protected from the risks of e.g. ulcers, gastric cancers and 
potentially coronary heart disease. Future studies if potential benefits of H. pylori infection 
are dependent on age when infected and age for eradication would be interesting to see. A 
study of a larger sample group, and/or a sample group where H. pylori is more prevalent than 
in Östhammar would be needed in order to investigate this question. 
The diseases previously studied in relation to H. pylori (ulcers, gastric cancer, GERD, 
esophageal cancer, asthma and allergy, autoimmune diseases, anemia and coronary heart 
disease) are different regarding risk for disease or on ongoing impact of the perceived health. 
The overall question whether H. pylori overall is harmful or beneficial for humans cannot be 
answered in a cross-sectional study investigating solely self-rated health. Eventual impact of 
dyspepsia, anemia, general feelings of sickness, asthma and allergy could here have been 
detected, but for diseases like cancer and coronary heart disease a prospective longitudinal 
study concentrating at risk would be better. Since the study is a part of LongGERD that has 
run since 1988 (37) this could be a future follow-up study. 
In the present study, blood test for hemoglobin (Hb) was also taken together with serology 
and other standard analyses. Considering H. pylori’s known correlation to anemia, it would 
have been interesting to study whether anemia or low Hb was more prevalent in positive 
individuals. Furthermore, the symptoms of anemia (mainly tiredness and physical fatigue) is 
associated with lower self-rated health, why the three parameters’ relationship would have 
been interesting to see in further studies. 
In our study we have not detected any association between self-rated health and H. pylori, 
which could come from poor variance in the material and thus low power. For future studies it 
would be interesting to examine whether H. pylori infection is correlated to specific 
extragastric symptoms, which previously have been associated to increased inflammatory 
factors such as tiredness, pain and depression for example. Moreover, studies investigating 
risk, and studies concerning perceived health and symptoms using more specific and sensitive 
methods when living as a carrier with H. pylori, would combined come closer to a more 
complete understanding about H. pylori and human coexistence. 
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For other “silent” pathogens, no correlation has been shown to SRH in previous studies (39). 
If the hypothesis is that silent pathogens elicit a systemic inflammatory response and that 
higher levels of circulating inflammatory factors influences the experienced well-being – it 
does not seem that self-rated health is a measurement sensitive enough to prove it. 
Furthermore, a study design that measures all three components hypothesized to interplay 
would be the most accurate for our aim; cytokines, infections burden, symptoms and self-
rated health. 
Conclusions  
We have not found any correlation between H. pylori infection and lower or higher self-rated 
health. 
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